|
rs11209026 |
SNP |
PedAM |
snpId=rs11209026; pubmedId=22130325; geneId=3605; geneSymbol=IL17A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis.; score=0.032722371; Year=2012; geneSymbol_dbSNP=IL23R; CHROMOSOME=1; POS=67240275; REF=G; ALT=A |
details
|
|
|
rs11209026 |
SNP |
PedAM |
snpId=rs11209026; pubmedId=22130325; geneId=149233; geneSymbol=IL23R; diseaseId=umls:C0003873; sourceId=BeFree; sentence=IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis.; score=0.012811307; Year=2012; geneSymbol_dbSNP=IL23R; CHROMOSOME=1; POS=67240275; REF=G; ALT=A |
details
|
|
|
rs11209026 |
SNP |
PedAM |
snpId=rs11209026; pubmedId=25387578; geneId=7124; geneSymbol=TNF; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The present study aimed to determine the association between the polymorphic variants of the IL-17A (rs2275913), IL-17F (rs763780) and IL-23R (rs11209026) genes and RA susceptibility, progression and response to therapy with TNF-¦Á inhibitors.; score=0.425384406; Year=2014; geneSymbol_dbSNP=IL23R; CHROMOSOME=1; POS=67240275; REF=G; ALT=A |
details
|
|
|
rs1133104 |
SNP |
PedAM |
snpId=rs1133104; pubmedId=17665455; geneId=50856; geneSymbol=CLEC4A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The SNP rs1133104 in the dendritic cell immunoreceptor gene (DCIR), and a haplotype including that marker and 4 other SNPs in DCIR and its vicinity showed an indication of allelic association with susceptibility to RA in patients who were negative for antibodies to cyclic citrullinated peptide (anti-CCP), with respective odds ratios of 1.27 (95% confidence interval [95% CI] 1.06-1.52; uncorrected P = 0.0073) and 1.37 (95% CI 1.12-1.67; uncorrected P = 0.0019).; score=0.00408156; Year=2007; geneSymbol_dbSNP=CLEC4A; CHROMOSOME=12; POS=8138526; REF=T; ALT=G |
details
|
|
|
rs1143679 |
SNP |
PedAM |
snpId=rs1143679; pubmedId=19714582; geneId=3684; geneSymbol=ITGAM; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.000814326; Year=2009; geneSymbol_dbSNP=ITGAM; CHROMOSOME=16; POS=31265490; REF=G; ALT=A |
details
|
|
|
rs1143679 |
SNP |
PedAM |
snpId=rs1143679; pubmedId=19714582; geneId=54899; geneSymbol=PXK; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.125005506; Year=2009; geneSymbol_dbSNP=ITGAM; CHROMOSOME=16; POS=31265490; REF=G; ALT=A |
details
|
|
|
rs1143679 |
SNP |
PedAM |
snpId=rs1143679; pubmedId=19714582; geneId=55024; geneSymbol=BANK1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.003181358; Year=2009; geneSymbol_dbSNP=ITGAM; CHROMOSOME=16; POS=31265490; REF=G; ALT=A |
details
|
|
|
rs1143679 |
SNP |
PedAM |
snpId=rs1143679; pubmedId=19714582; geneId=4204; geneSymbol=MECP2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.120814326; Year=2009; geneSymbol_dbSNP=ITGAM; CHROMOSOME=16; POS=31265490; REF=G; ALT=A |
details
|
|
|
rs11541076 |
SNP |
PedAM |
snpId=rs11541076; pubmedId=20448286; geneId=11213; geneSymbol=IRAK3; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Several SNPs mapping to the TLR and NFkappaB signalling systems demonstrated association with anti-TNF response as a whole and, in particular, with response to etanercept. Validation of these findings in an independent cohort is now warranted.]; score=0.002367032; Year=2010; geneSymbol_dbSNP=IRAK3; CHROMOSOME=12; POS=66254548; REF=A; ALT=T |
details
|
|
|
rs11556924 |
SNP |
PedAM |
snpId=rs11556924; pubmedId=24286297; geneId=51530; geneSymbol=ZC3HC1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis.; score=0.000271442; Year=2013; geneSymbol_dbSNP=ZC3HC1; CHROMOSOME=7; POS=130023656; REF=C; ALT=T |
details
|
|
|
rs11568821 |
SNP |
PedAM |
snpId=rs11568821; pubmedId=17535987; geneId=5133; geneSymbol=PDCD1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Previous investigations have also demonstrated that an intronic polymorphism (termed PD1.3; SNP ID rs11568821) in the programmed cell death (PDCD1) gene was associated with systemic lupus erythematosus and rheumatoid arthritis.; score=0.015449781; Year=2007; geneSymbol_dbSNP=PDCD1;LOC105373977; CHROMOSOME=2; POS=241851760; REF=C; ALT=T,G |
details
|
|
|
rs11568835 |
SNP |
PedAM |
snpId=rs11568835; pubmedId=25089940; geneId=1950; geneSymbol=EGF; diseaseId=umls:C0003873; sourceId=BeFree; sentence=EGF rs11568835 G/A polymorphism is associated with increased risk of rheumatoid arthritis.; score=0.000814326; Year=2015; geneSymbol_dbSNP=EGF; CHROMOSOME=4; POS=109911514; REF=G; ALT=A |
details
|
|
|
rs11574851 |
SNP |
PedAM |
snpId=rs11574851; pubmedId=20448286; geneId=4791; geneSymbol=NFKB2; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Several SNPs mapping to the TLR and NFkappaB signalling systems demonstrated association with anti-TNF response as a whole and, in particular, with response to etanercept. Validation of these findings in an independent cohort is now warranted.]; score=0.007101096; Year=2010; geneSymbol_dbSNP=NFKB2; CHROMOSOME=10; POS=102401202; REF=C; ALT=T |
details
|
|
|
rs11574914 |
SNP |
PedAM |
snpId=rs11574914; pubmedId=24390342; geneId=6366; geneSymbol=CCL21; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Genetics of rheumatoid arthritis contributes to biology and drug discovery.; score=0.270747672; Year=2013; geneSymbol_dbSNP=CCL21; CHROMOSOME=9; POS=34710341; REF=G; ALT=A |
details
|
|
|
rs11591741 |
SNP |
PedAM |
snpId=rs11591741; pubmedId=20448286; geneId=1147; geneSymbol=CHUK; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Several SNPs mapping to the TLR and NFkappaB signalling systems demonstrated association with anti-TNF response as a whole and, in particular, with response to etanercept. Validation of these findings in an independent cohort is now warranted.]; score=0.002909916; Year=2010; geneSymbol_dbSNP=CHUK; CHROMOSOME=10; POS=100216744; REF=G; ALT=C |
details
|
|
|
rs1160542 |
SNP |
PedAM |
snpId=rs1160542; pubmedId=20498205; geneId=6775; geneSymbol=STAT4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.316739695; Year=2010; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100215693; REF=G; ALT=A |
details
|
|
|
rs1160542 |
SNP |
PedAM |
snpId=rs1160542; pubmedId=20498205; geneId=3798; geneSymbol=KIF5A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.254473634; Year=2010; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100215693; REF=G; ALT=A |
details
|
|
|
rs1160542 |
SNP |
PedAM |
snpId=rs1160542; pubmedId=20498205; geneId=3899; geneSymbol=AFF3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.129001189; Year=2010; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100215693; REF=G; ALT=A |
details
|
|
|
rs1160542 |
SNP |
PedAM |
snpId=rs1160542; pubmedId=20498205; geneId=1493; geneSymbol=CTLA4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.345272224; Year=2010; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100215693; REF=G; ALT=A |
details
|
|
|
rs1160542 |
SNP |
PedAM |
snpId=rs1160542; pubmedId=20498205; geneId=26191; geneSymbol=PTPN22; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.524345611; Year=2010; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100215693; REF=G; ALT=A |
details
|
|
